BRIDGEWAY CAPITAL MANAGEMENT, LLC
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 1107261
HOUSTON, TX
Position in RIGL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,858,078
+$4,321,847 QoQ
Shares Held
124,184
+891.9% QoQ
Ownership
0.665%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#24
of 155 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $87,496,321 across 108 Biotechnology names. RIGL ranks #4 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GLUE |
Monte Rosa Therapeutics, Inc.
|
552,566 | $13,372,097 | |
| 2 | INVA |
Innoviva, Inc.
|
350,253 | $7,954,245 | |
| 3 | PBYI |
Puma Biotechnology, Inc.
|
791,616 | $6,420,005 | |
| 4 | RIGL |
Rigel Pharmaceuticals Inc
This page
|
124,184 | $4,858,078 | |
| 5 | EXEL |
Exelixis, Inc.
|
66,100 | $3,596,501 | |
| 6 | CRMD |
CorMedix Inc.
|
434,132 | $3,407,936 | |
| 7 | KROS |
Keros Therapeutics, Inc.
|
265,017 | $2,835,681 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
22,000 | $1,794,540 |
All Filings in RIGL
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,858,078 | 124,184 | Shares | Sole | 2026-08-14 | |
| 2025-12-31 | $536,231 | 12,520 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $636,575 | 22,470 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $654,988 | 34,970 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $853,985 | 47,470 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,057,473 | 62,870 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,044,257 | 64,540 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $530,518 | 64,540 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $881,192 | 595,400 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $972,080 | 670,400 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $641,736 | 594,200 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $483,750 | 375,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $343,200 | 260,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $487,500 | 325,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $383,500 | 325,000 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||